Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of human circular RNA in preparation of heart disease-related products

A technology of heart disease and related products, applied in the field of biomedicine, can solve the problems of unfavorable diagnosis, specificity, poor sensitivity and stability, etc., and achieve the effect of good detection sensitivity and specificity, significant changes, and high stability

Inactive Publication Date: 2020-07-14
QINGDAO UNIV
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] At present, there are mainly three methods for the diagnosis of coronary heart disease: clinical manifestations, electrocardiogram, and blood markers represented by troponin. Intervention and treatment before irreversible necrosis of the myocardium

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of human circular RNA in preparation of heart disease-related products
  • Application of human circular RNA in preparation of heart disease-related products
  • Application of human circular RNA in preparation of heart disease-related products

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0055] Identification of circHED in human blood:

[0056] CircHED in blood was identified by inverse PCR. Take 500 μl of human blood, add 500 μl Trizol (Takara RNAiso Plus 9108), turn the centrifuge tube upside down several times, let it stand at room temperature for 15 minutes, extract total RNA according to the instructions, and further use the Takara RR0037A reverse transcription kit to pair random primers Random 6-mer RNA was reverse-transcribed to synthesize cDNA; another 300 μl of blood was extracted through the TIANGEN Blood Genomic DNA Extraction System (DP349) to extract genomic DNA (gDNA). Using blood cDNA or gDNA as a template, the sequence of the circHED terminal junction site was amplified by PCR using the reverse primer, and the forward primer was used as a control. The amplified products were detected by agarose gel electrophoresis, and the amplified products using cDNA as a template were subjected to Sanger sequencing.

[0057] The primer sequences are as fol...

Embodiment 2

[0067] Detection of circHED in the blood of patients with myocardial infarction:

[0068] In this experiment, 50 blood samples were collected from normal people with no history of cardiovascular disease and 50 patients with acute myocardial infarction. Patients with myocardial infarction should meet the following clinical manifestations: (1) angina pectoris lasted for more than 30 minutes; (2) ECG showed typical myocardial infarction features; 3) Increased levels of molecular markers such as creatine kinase, lactate dehydrogenase, and troponin T or I in the blood. Blood RNA was extracted and cDNA was synthesized according to the method described in Example 1, and 18SrRNA was used as an internal reference, and qPCR was used for detection, and 2 -ΔΔCT The relative expression level of circHED in blood was calculated by the method. Novazan ChamQ Universal SYBR qPCR qPCR Master Mix was used in the qPCR kit, and the experimental operation was performed according to the instructions...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides an application of a human circular RNA in preparation of heart disease-related products and relates to the technical field of bio-medicines. The human circular RNA applied to preparation of the heart disease-related products is a nucleic acid containing a sequence as shown in SEQ ID NO.1, or a bioactive functional fragment, a variant or a derivative of the nucleic acid containing the sequence as shown in the SEQ ID NO.1. The human circular RNA is applied to preparation of the heart disease-related products, so that the human circular RNA can combine detection sensitivitywith specificity as a diagnostic marker.

Description

technical field [0001] The invention relates to the technical field of biomedicine, in particular to the application of a human circular RNA in the preparation of products related to heart disease. Background technique [0002] At present, there are mainly three methods for the diagnosis of coronary heart disease: clinical manifestations, electrocardiogram, and blood markers represented by troponin. Intervention and treatment before irreversible necrosis of the myocardium occurs. Therefore, it is imperative to develop an improved diagnostic product for coronary heart disease. [0003] In view of this, the present invention is proposed. Contents of the invention [0004] The first object of the present invention is to provide an application of human circular RNA in the preparation of products related to heart disease. [0005] The second object of the present invention is to provide a method for detecting the human-derived circular RNA for non-diagnostic and therapeutic ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/6883C12N15/11
CPCC12Q1/6883C12Q2600/158C12Q2600/178C12Q2600/166
Inventor 王建勋李萌阳丁巍
Owner QINGDAO UNIV